Results 231 to 240 of about 41,832 (264)

Evaluating cannabidiol (CBD) expectancy effects on acute stress and anxiety in healthy adults: a randomized crossover study

Psychopharmacology, 2021
Igor Yakovenko, Toni Spinella, Sean Barrett   +2 more
exaly  

A Multiple Correspondence Analysis of Patterns of CBD Use in Hemp and Marijuana Users

Frontiers in Psychiatry, 2021
Mackenzie Taylor, Francesca Filbey
exaly  

CBD CANNABINOIDS AND CBD CANNABINOID ANALOGUES

2022
BOSCH H WILLIAM, DOLLE ROLAND, BEARE NEIL, BLASKOVICH MARK   +3 more
openaire   +1 more source

Translational Investigation of the Therapeutic Potential of Cannabidiol (CBD): Toward a New Age

Frontiers in Immunology, 2018
JOSÉ Crippa, FRANCISCO Guimarães, Campos A C   +2 more
exaly  

Pharmacokinetic and behavioural profile of THC, CBD, and THC+CBD combination after pulmonary, oral, and subcutaneous administration in rats and confirmation of conversion in vivo of CBD to THC

European Neuropsychopharmacology, 2017
Marie Balikova, Tomáš Palenicek, Tomáš Hlozek   +2 more
exaly  

Cannabidiol (CBD) use in psychiatric disorders: A systematic review

NeuroToxicology, 2019
Caroline Zangani, Fabrizio Schifano, Stefania Chiappini   +2 more
exaly  

<p>Therapeutic Potential of Cannabidiol (CBD) for Skin Health and Disorders</p>

Clinical, Cosmetic and Investigational Dermatology, 2020
Sunghan Yim, Sudhir M Baswan
exaly  

Conversion of cannabidiol (CBD) to Δ9-tetrahydrocannabinol (Δ9-THC) during protein precipitations prior to plasma samples analysis by chromatography – Troubles with reliable CBD quantitation when acidic precipitation agents are applied

Talanta, 2020
Michal P Dybowski, Andrzej Dawidowicz, Rafal Typek   +2 more
exaly  

Pharmacokinetic and Safety Evaluation of Various Oral Doses of a Novel 1:20 THC:CBD Cannabis Herbal Extract in Dogs

Frontiers in Veterinary Science, 2020
Jane Alcorn, Kevin Cosford, Alcorn Jane   +2 more
exaly  

Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report

Journal of Psychopharmacology, 2011
JOSÉ Crippa, Antonio Zuardi, Fabio Luis Souza-Duran   +2 more
exaly